News Release

February 26,2019
FunPep is approved the PⅠ/Ⅱa clinical trial plan of FPP003 (antibody-inducing peptide) by HREC in Australia.
February 18,2019
FunPep contracts the joint research agreement with Shionogi for antibody-inducing peptide on pain territory.